周一,在宣布与Bristol Myers Squibb (BMS)就开发prime edited ex vivo T细胞疗法达成重大合作后,TD Cowen重申了对Prime Medicine (NASDAQ:PRME)的买入评级。这笔潜在价值超过35亿美元的交易还包括向Prime Medicine支付1.1亿美元的预付款。 此次合作旨在推进Prime Medicine的研发管线,重点关注prim ...
the comments you supply may be edited and published on any BBC media worldwide. Please state in your email if you do not want your comments published. Your details will not be given to anyone ...